Skip to main content
. 2020 Jul 15;181:104878. doi: 10.1016/j.antiviral.2020.104878

Table 3.

Inhibitory effect of remdesivir-diltiazem combined treatment against SARS-CoV-2 in vitro. For each experimental condition, IC50, CC50 and the corresponding SI values are listed.

Combination treatment IC50 (μM) CC50 (μM) SI
Remdesivir 0.987 275 278.62
Remdesivir
+
Diltiazem 5.62 μM
0.627 267 425.83
Remdesivir
+
Diltiazem 11.5 μM
0.116 2301.72
Remdesivir
+
Diltiazem 22.5 μM
0.228 1171.05
Diltiazem >45 424 <9.42
Diltiazem
+
Remdesivir 0.625 μM
5.268 414 78.59
Diltiazem
+
Remdesivir 1.25 μM
1.892 218.81
Diltiazem
+
Remdesivir 2.5 μM
0.554 747.29